ContraFect (NASDAQ:CFRX) Coverage Initiated by Analysts at StockNews.com

StockNews.com started coverage on shares of ContraFect (NASDAQ:CFRX – Free Report) in a report published on Sunday morning. The brokerage issued a sell rating on the biotechnology company’s stock. ContraFect Price Performance Shares of NASDAQ CFRX opened at $0.59 on Friday. The firm’s 50-day moving average price is $0.95 and its two-hundred day moving average […]

Related Keywords

United States , ,Dimensional Fund Advisors ,Contrafect Company Profile ,Envestnet Asset Management Inc ,Virtu Financial ,Contrafect Corporation ,Free Report ,Get Free Report ,Asset Management ,Fund Advisors ,Street Corp ,Sigma Investments ,Fect Corporation ,Contrafect Daily ,Contrafect ,Nasdaq Cfrx ,Cfrx ,Medical ,Initiated Coverage ,Stocknews Com ,